Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Immunomedics (IMMU) - moderated -- Ignore unavailable to you. Want to Upgrade?

To: stockdoc77 who wrote (59143)	12/21/2020 8:42:28 PM
From: dorightbythem	Read Replies (1) \| Respond to of 63329

Fourth Mutation!!! Come on 2020. Spreads easier and more virulent. Nuts just nuts.

To: stockdoc77 who wrote (59143)	12/22/2020 1:25:24 PM
From: allatwwk	1 Recommendation Recommended By KeeptheFaith Read Replies (1) \| Respond to of 63329

stockdoc, glad you got your first shot. Curious about your comment on youth getting vaccinated. Have there been any trials with people under 16? Thought the Moderna age cut-off was 18 and Pfizer 16. It may not seem as urgent since the impact on these ages seems less, but under 18 = 20% of the population, which means herd immunity becomes very difficult if they aren't part of the process. Couple more things. Had an odd occurrence on Facebook the other day. Commented on a friends picture. Then noticed the next person who'd commented on the same photo was Hope Rugo. One and the same from the ASCENT study. So I replied to her, thanking her for her work. Don't know her, but obviously, she's been a big part part of the Trodelvy story and made a world of difference. Figured it was a chance to say thank you, even if it happened in a very odd way. Second, I had an idea on how to get more people in the vaccine line which would also help cover various costs. And the folks at STAT thought enough of it, provocative as it is, to put it out there. So here's the piece. statnews.com